Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication

2008135 citationsJournal Article

Authors

A. Ferretto Parodi · United States Nuclear Regulatory Commission

Marta Sessarego · University of Genoa

Alfredo Greco · United States Nuclear Regulatory Commission

Marco Bazzica · University of Genoa

Gilberto Filaci · University of Genoa

Maurizio Setti · University of Genoa

Edoardo Savarino

Abstract

These data suggest that SIBO occurs more frequently in SSc patients than in controls. Intestinal symptoms in these patients may be related to this syndrome and its eradication seems useful to improve clinical features. OCTT is significantly delayed in SSc patients, suggesting an impairment of intestinal motility, a further risk factor for the development of SIBO.

Topics & Keywords

Systemic Sclerosis and Related Diseases Dermatologic Treatments and Research Inflammatory Myopathies and Dermatomyositis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 103, Issue 5, pp. 1257-1262

DOI: 10.1111/j.1572-0241.2007.01758.x

Field-Weighted Citation Impact: 3.29